Literature DB >> 6838515

Subcellular distribution of gamma-hydroxybutyrate binding sites in rat brain principal localization in the synaptosomal fraction.

M Maitre, J F Rumigny, C Cash, P Mandel.   

Abstract

gamma-Hydroxybutyrate binding sites, first described on crude membranes from rat brain, have been further studied on subcellular fractions. The nerve ending fraction (fraction C) exhibits the maximal capacity for GHB binding. The two classes of binding sites (high and low affinities) described for the crude membrane preparation are enriched in this synaptosomal fraction. This result is further evidence in favor of a role for GHB as a neurotransmitter or neuromodulator in rat brain.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6838515     DOI: 10.1016/0006-291x(83)91289-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  The GABAB-receptor antagonist, CGP 35348, antagonises gamma-hydroxybutyrate- and baclofen-induced alterations in locomotor activity and forebrain dopamine levels in mice.

Authors:  H Nissbrandt; G Engberg
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

2.  Effects of phospholipases, proteases and neuraminidase on gamma-hydroxybutyrate binding sites.

Authors:  V Hechler; M Mersel; H Dreyfus; M Maitre
Journal:  Mol Cell Biochem       Date:  1990-03-05       Impact factor: 3.396

3.  gamma-Hydroxybutyrate uptake by rat brain striatal slices.

Authors:  V Hechler; J J Bourguignon; C G Wermuth; P Mandel; M Maitre
Journal:  Neurochem Res       Date:  1985-03       Impact factor: 3.996

4.  gamma-Hydroxybutyric acid (GHBA) induces pacemaker activity and inhibition of substantia nigra dopamine neurons by activating GABAB-receptors.

Authors:  G Engberg; H Nissbrandt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-11       Impact factor: 3.000

5.  Improvement in γ-hydroxybutyrate-induced contextual fear memory deficit by systemic administration of NCS-382.

Authors:  Keita Ishiwari; Ratna Sircar
Journal:  Neuroreport       Date:  2016-06-15       Impact factor: 1.837

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.